Skip to content

Bench7, Inc.

Country not established

Devices
2

What Bench7, Inc. makes

Bench7, Inc. manufactures the SugarBug continuous glucose monitoring (CGM) system, designed for real-time blood glucose tracking in individuals with diabetes. The device provides automated glucose readings and alerts, intended for both clinical and consumer use.

The SugarBug system is classified as a Class II medical device under FDA regulations and has been authorised through the 510(k) clearance process. The company is headquartered in the United States.

AI-generated from registry data, 20 Sep 2026. Not verified by deviCERTS or the manufacturer.

Catalogue2

Newest first, rows 1-2 of 2

  • SugarBot 1.1.0

    None Registry: GUDID Class:II
  • SugarBug (1.x) Ref K250264

    Active Regimes: 510(k) Registry: 510(k) Class:II

Company details

DUNS number
138396139

Frequently asked questions

How many devices does Bench7, Inc. have in the registry?

The registry currently lists 2 devices for Bench7, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Bench7, Inc.'s devices?

Among its 2 most recently registered devices, Bench7, Inc. has devices listed in FDA 510(k) (1 device) and FDA GUDID (1 device). A device can be listed in more than one registry, so these counts overlap.

What risk classes do Bench7, Inc.'s devices fall under?

Among its 2 most recently registered devices, the classes recorded for Bench7, Inc.'s devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Bench7, Inc. in the registry?

The most recently registered devices listed for Bench7, Inc. include SugarBot 1.1.0 and SugarBug (1.x).

Generated automatically from registry data and not verified by a human reviewer.